Evidence map›Paper›PMID 32548209›Full record

ArticleOpen forum infectious diseases2020

Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review.

Tom Wai-Hin Chung, Siddharth Sridhar, Anna Jinxia Zhang, Kwok-Hung Chan, Hang-Long Li, Fergus Kai-Chuen Wong, Ming-Yen Ng, Raymond King-Yin Tsang, Andrew Chak-Yiu Lee, Zhimeng Fan and 13 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 8 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 8 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Prevalence and Factors Associated with Olfactory Dysfunction in Individuals with COVID-19 in Brazil: A Study of 20,669 Cases from 2020 to 2021.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Article
  15. Article
  16. Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 2 countries.

Tom Wai-Hin ChungDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Siddharth SridharDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Anna Jinxia ZhangDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Kwok-Hung ChanDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Hang-Long LiLi Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Fergus Kai-Chuen WongDepartment of Ear, Nose and Throat Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Ming-Yen NgDepartment of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China.
Raymond King-Yin TsangDivision of Otolaryngology, Department of Surgery, The University of Hong Kong, Hong Kong, China.
Andrew Chak-Yiu LeeDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Zhimeng FanDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Ronnie Siu-Lun HoDepartment of Pathology, Queen Mary Hospital, Hong Kong, China.
Shiobhon Yiu LukDepartment of Diagnostic Radiology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Wai-Kuen KanDepartment of Diagnostic Radiology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Sonia Hiu-Yin LamDepartment of Diagnostic Radiology, Queen Mary Hospital, Hong Kong, China.
Alan Ka-Lun WuDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Sau-Man LeungDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Wai-Ming ChanDepartment of Adult Intensive Care, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Pauline Yeung NgDepartment of Adult Intensive Care, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Kelvin Kai-Wang ToDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Vincent Chi-Chung ChengDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Kwok-Cheung LungDepartment of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Ivan Fan-Ngai HungState Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China.
Kwok-Yung YuenDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
University of Hong Kong · HKPamela Youde Nethersole Eastern Hospital · CNQueen Mary Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlfactory dysfunction (OD) has been reported in coronavirus disease 2019 (COVID-19). However, there are knowledge gaps about the severity, prevalence, etiology, and duration of OD in COVID-19 patients.

methodsOlfactory function was assessed in all participants using questionnaires and the butanol threshold test (BTT). Patients with COVID-19 and abnormal olfaction were further evaluated using the smell identification test (SIT), sinus imaging, and nasoendoscopy. Selected patients received nasal biopsies. Systematic review was performed according to PRISMA guidelines. PubMed items from January 1, 2020 to April 23, 2020 were searched. Studies that reported clinical data on olfactory disturbances in COVID-19 patients were analyzed.

resultsWe included 18 COVID-19 patients and 18 controls. Among COVID-19 patients, 12 of 18 (67%) reported olfactory symptoms and OD was confirmed in 6 patients by BTT and SIT. Olfactory dysfunction was the only symptom in 2 patients. Mean BTT score of patients was worse than controls (

conclusionsOlfactory dysfunction is common in COVID-19 and may be the only symptom. Coronavirus disease 2019-related OD can be severe and prolonged. Mucosal infiltration by CD68

Indexed as

anosmiaCOVID-19olfactory dysfunctionSARS-CoV-2smell impairment

Identifiers

PMID32548209
PMCPMC7284010
OpenAlexW3033812091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.